does tirzepatide cause thyroid cancer Using GLP-1 Drugs, Like Zepbound or Wegovy, Increase Your Risk of Cancer? Thyroid Cancer Risk : r/Zepbound

The inclusion of six population-based cohorts from diverse geographical settings enhances the generalizability of the findings. The authors also remarked that, The median follow-up period of 1.8 to 3.0 years is insufficient to evaluate long-term risks. In addition, the studys focus on populations with type 2 diabetes may limit is applicability to non-diabetic populations, a growing group of GLP-1RA users, particularly for obesity management. About the Journal Thyroid , the official journal of the American Thyroid Association , (ATA ) is an authoritative peer-reviewed journal published monthly online with open access options and in print

More Than a Number on a Scale Medical weight loss can be a powerful option for patients dealing with obesity, metabolic dysfunction, or hormone-related weight gain

Zajda J, Wadych E, Ogorek K, Drozd M, Matczuk M

The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks

,